Is ozone therapy therapeutic?

Perspectives in Biology and Medicine

Volumn 42, Issue 1, 1998, Pages 131-143

  Bocci, Velio ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

OZONE;

ALTERNATIVE MEDICINE; BLOOD TRANSFUSION; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW;

EID: 0032463791     PISSN: 00315982     EISSN: None     Source Type: Journal    
DOI: 10.1353/pbm.1998.0056     Document Type: Review

References (43)

1. U.S. ENVIRONMENTAL PROTECTION AGENCY. Air Quality Criteria for Ozone and Other Photochemical Oxidants. Environmental Criteria and Assessment Office. Research Triangle Park, NC: Publication no. EPA-600/8-84-020aF, 1986.
2. SCHMIEDEN, U., and WILD, A. The contribution of ozone to forest decline. Physiol. Plant. 94:371-78, 1995.
3. CROSS, C.E.; EISERICH, J.P.; and HALLIWELL, B. General biological consequences of inhaled environmental toxicants. In The Lung: Scientific Foundations, edited by R.G. CRYSTAL and J.B. WEST. Philadelphia: Lippincott-Raven Publishers, 1997, 2421-37.
4. VIEBAHN, R. The Use of Ozone in Medicine. Heidelberg: Karl F. Haug Publishers, 1994.
5. WEHRLI, F., and STEINBART, H. Erfahrungen mit der Haematogenen Oxydations-Therapie (HOT). Ars Medici 10:44-51, 1954.
6. BOCCI, V. Ozone as a bioregulator: Pharmacology and toxicology of ozone-therapy today. J. Biol. Regulat. Homeost. Agent. 10:31-53, 1996.
7. PRYOR, W.A. Mechanisms of radical formation from reactions of ozone with target molecules in the lung. Free Radical Biol. Med. 17:451-65, 1994.
8. BOCCI, V., and PAULESU, L. Studies on the biological effects of ozone: 1. Induction of interferon gamma on human leucocytes. Haematologica 75: 510-15, 1990.
9. PAULESU, L.; LUZZI, E.; and BOCCI, V. Studies on the biological effects of ozone: 2. Induction of tumor necrosis factor (TNF-α) on human leucocytes. Lymphokine Cylokine Res. 10:409-12, 1991.
10. BOCCI, V.; LUZZI, E.; CORRADESCHI, F.; et. al. Studies on the biological effects of ozone: 3. An attempt to define conditions for optimal induction of cytokines. Lymphokine Cytokine Res. 12:121-26, 1993.
11. BOCCI, V.; LUZZI, E.; CORRADESCHI, F.; et. al. Studies on the biological effects of ozone: 6. Production of transforming growth factor β1 by human blood after ozone treatment. J. Biol. Regulat. Homeost. Agent 8:108-12, 1994.
12. LOS, M.; DRÖGE, W.; STRICKER, K.; et al. Hydrogen peroxide as a potent activator of T lymphocyte functions. Eur. J. Immunol. 25:159-65, 1995.
13. SEN. R., and BALTIMORE, D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46:705-16, 1986.
14. ARSALANE, K.; GOSSET, P.; VANHEE, D.; et al. Ozone stimulates synthesis of inflammatory cytokines by alveolar macrophages in vitro. Amer. J. Respir. Cell Molec. Biol. 13:60-68, 1995.
15. JASPERS, I.; FLESCHER, E.; and CHEN, L.C. Ozone-induced IL-8 expression and transcription factor binding in respiratory epithelial cells. Amer. J. Physiol. 272:L504-11 1997.
16. VIEBAHN-HÄNSLER, R. Einfluss auf den Erythrozytenstoffwechsel. In Ozon-Handbuch: Grundlagen - Prävention - Therapie, edited by L.S. BECK and R. VIEBAHN-HÄNSLER. Landsberg/Lech: Ecomed, 1995, 1-15.
17. PRYOR, W.A.; SQUADRITO, G.L.; and FRIEDMAN, M. The cascade mechanism to explain ozone toxicity: The role of lipid ozonation products. Free Rad. Biol. Med. 19:935-41, 1995.
18. SERHAN, C.N.; HAEGGSTRÖM, J.Z.; and LESLIE, C.C. Lipid mediator networks in cell signaling: Update and impact of cytokines. FASEB J. 10:1147-58, 1996.
19. HAMILTON, R.F. JR.; HAZBUN, M.E.; JUMPER, C.A.; et al. 4-hydroxynonenal mimics ozone-induced modulation of macrophage function ex vivo. Amer. J. Respir. Cell Molec. Biol. 15:275-82, 1996.
20. LEONARDUZZI, G.; SCAVAZZA, A.; BIASI, F.; et al. The lipid peroxidation end product 4-hydroxy-2,3-nonenal upregulates transforming growth factor β1 expression in the macrophage lineage: A link between oxidative injury and fibrosclerosis. FASEB J. 11:851-57, 1997.
21. MORROW, J.D., and JACKSON ROBERTS, L. The isoprostanes: Unique bioactive products of lipid peroxidation. Prog. Lipid Res. 36:1-21, 1997.
22. HALLIWELL, B. Antioxidants in human health and disease. Ann. Rev. Nutr. 16:33-50, 1996.
23. BOCCI, V.; LUZZI, E.; CORRADESCHI, F.; et al. Studies on the biological effects of ozone: 4. Cytokine production and glutathione levels in human erythrocytes. J. Biol. Regulat. Homeost. Agent 7:133-38, 1993.
24. SEN, C.K., and PACKER, L. Antioxidant and redox regulation of gene transcription. FASEB J. 10:709-20, 1996.
25. SUZUKI, Y.J.; FORMAN, H.J.; and SEVANIAN, A. Oxidants as stimulators of signal transduction. Free Rad. Biol. Med. 22:269-85, 1997.
26. MURRY, C.E.; JENNINGS, R.B.; and REIMER, K.A. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 74:1124-36, 1986.
27. HERNÀNDEZ, F.; MENÉNDEZ, S.; and WONG, R. Decrease of blood choles-terol and stimulation of antioxidative response in cardiopathy patients treated with endovenous ozone therapy. Free Rad. Biol. Med. 19:115-19, 1995.
28. BOCCI, V. Does ozone therapy normalize the cellular redox balance? Med. Hypotheses 46:150-54, 1996.
29. KANGASJÄRVI, J.; TALVINEN, J.; UTRIAINEN, M.; et al. Plant defence systems induced by ozone. Plant Cell Environ. 17:783-94, 1994.
30. RANIERI, A.; D'URSO, G.; NALI, C.; et al. Ozone stimulates apoplastic antioxidant systems in pumpkin leaves. Physiol. Plant 97:381-87, 1996.
31. SHARMA, Y.K., and DAVIS, K.R. The effects of ozone on antioxidant responses in plants. Free Rad. Biol. Med. 23:480-88, 1997.
32. AMES, B.N.; SHIGENAGA, M.K.; and HAGEN, T.M. Oxidants, antioxidants, and the degenerative diseases of aging. Proc. Nat. Acad. Sci. USA 90:7915-22, 1993.
33. SCHWARZ, K.B. Oxidative stress during viral infection: A review. Free Rad. Biol. Med. 21:641-49, 1996.
34. TOYOKUNI, S.; OKAMOTO, K.; YODOI, J.; et al. Persistent oxidative stress in cancer. FEBS Lett. 358:1-3, 1995.
35. SIMONIAN, N.A., and COYLE, J.T. Oxidative stress in neurodegenerative diseases. Ann. Rev. Pharmacol. Toxicol. 36:83-106, 1996.
36. SU, W.Y., and GORDON, T. In vivo exposure to ozone produces an increase in a 72-kDa heat shock protein in guinea pigs. J. Appl. Physiol. 83:707-11, 1997.
37. MIROSHIN, S.J., and KONTORSHIKOVA, C.N. The use of ozonetherapy technology in the treatment of modern war surgical trauma. In The Ozone in Biology and Medicine: Second All Russian Scientific-Practical Conference, September 6-8, 1995, edited by R. VIEBAHN-HÄNSLER. Nizhni Novgorod, Russia: Russian Association of Ozonetherapy, Reshetnikovskaya street 2, 1995.
38. BECK, L.S.; DEGUZMAN, L.; LEE, W.P.; et al. One systemic administration of transforming growth factor-β1 reverses age- or glucocorticoid-impaired wound healing. J. Clin. Invest. 92:2841-49, 1993.
39. SWEET, F.; KAO, M.-S.; LEE, S.-C.D.; et al. Ozone selectively inhibits growth of human cancer cells. Science 209:931-33, 1980.
40. BOCCI, V. Ozonetherapy may act as a biological response modifier in cancer. Forsch. Komplementärmed. 5:54-60, 1998.
41. WERKMEISTER, H. Dekubitalgeschwüre und die Behandlung mit der Ozon-Unterdruckbegasung. In Ozon-Handbuck: Grundlagen - Prävention - Therapie, edited by L.S. BECK and R. VIEBHAN-HÄNSLER. Landsberg/Lech: Ecomed, 1995.
42. WONG, R.; MENENDEZ, S.; CASTAÑER, J.; et al. Ozonetherapy in ischemic cardiopathy. In Proceedings: Ozone in Medicine. 12th World Congress of the International Ozone Association, 15-18 May 1995, Lille France, edited by INTERNATIONAL OZONE ASSOCIATION. Tours: Instaprint, 1995, 73-77.
43. TIBBLES, P.M., and EDELSBERG, J.S. Hyperbaric-oxygen therapy. N. Engl. J. Med. 334:1642-48, 1996.